These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19010788)

  • 1. The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation.
    Schröder R; Merten N; Mathiesen JM; Martini L; Kruljac-Letunic A; Krop F; Blaukat A; Fang Y; Tran E; Ulven T; Drewke C; Whistler J; Pardo L; Gomeza J; Kostenis E
    J Biol Chem; 2009 Jan; 284(2):1324-36. PubMed ID: 19010788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways.
    Yue L; Haroun S; Parent JL; de Brum-Fernandes AJ
    Bone; 2014 Mar; 60():112-21. PubMed ID: 24345643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2.
    Gallant MA; Slipetz D; Hamelin E; Rochdi MD; Talbot S; de Brum-Fernandes AJ; Parent JL
    Eur J Pharmacol; 2007 Feb; 557(2-3):115-23. PubMed ID: 17207480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: identification of a recycling motif.
    Roy SJ; Parent A; Gallant MA; de Brum-Fernandes AJ; Stanková J; Parent JL
    Eur J Pharmacol; 2010 Mar; 630(1-3):10-8. PubMed ID: 20035740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
    Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
    J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
    Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
    Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for lipid recognition by the prostaglandin D
    Liu H; Deepak RNVK; Shiriaeva A; Gati C; Batyuk A; Hu H; Weierstall U; Liu W; Wang L; Cherezov V; Fan H; Zhang C
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34341104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of the Human PGD
    Wang L; Yao D; Deepak RNVK; Liu H; Xiao Q; Fan H; Gong W; Wei Z; Zhang C
    Mol Cell; 2018 Oct; 72(1):48-59.e4. PubMed ID: 30220562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation.
    Kim KM; Gainetdinov RR; Laporte SA; Caron MG; Barak LS
    J Biol Chem; 2005 Apr; 280(13):12774-80. PubMed ID: 15687500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Breyer RM
    J Biol Chem; 2005 Sep; 280(37):32442-51. PubMed ID: 16030019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIV/Girdin activates Gαi and inhibits Gαs via the same motif.
    Gupta V; Bhandari D; Leyme A; Aznar N; Midde KK; Lo IC; Ear J; Niesman I; López-Sánchez I; Blanco-Canosa JB; von Zastrow M; Garcia-Marcos M; Farquhar MG; Ghosh P
    Proc Natl Acad Sci U S A; 2016 Sep; 113(39):E5721-30. PubMed ID: 27621449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
    Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
    Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytes.
    Kanda N; Ishikawa T; Watanabe S
    Biochem Pharmacol; 2010 Apr; 79(7):982-9. PubMed ID: 19925780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor.
    Kelley-Hickie LP; Kinsella BT
    Biochim Biophys Acta; 2006 Sep; 1761(9):1114-31. PubMed ID: 16956790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the promoter of human CRTh2, a prostaglandin D2 receptor.
    Quapp R; Madsen N; Cameron L
    Biochem Biophys Res Commun; 2007 Nov; 363(4):948-53. PubMed ID: 17910949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crth2 receptor signaling down-regulates lipopolysaccharide-induced NF-κB activation in murine macrophages
    Diwakar BT; Yoast R; Nettleford S; Qian F; Lee TJ; Berry S; Huffnagle I; Rossi RM; Trebak M; Paulson RF; Prabhu KS
    FASEB J; 2019 Nov; 33(11):12838-12852. PubMed ID: 31518163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of amino acids that are selectively involved in Gi/o activation by rat melanin-concentrating hormone receptor 1.
    Hamamoto A; Kobayashi Y; Saito Y
    Cell Signal; 2015 Apr; 27(4):818-27. PubMed ID: 25617691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2.
    Mathiesen JM; Ulven T; Martini L; Gerlach LO; Heinemann A; Kostenis E
    Mol Pharmacol; 2005 Aug; 68(2):393-402. PubMed ID: 15870392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses.
    Sugimoto H; Shichijo M; Okano M; Bacon KB
    Eur J Pharmacol; 2005 Nov; 524(1-3):30-7. PubMed ID: 16256979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.